192 related articles for article (PubMed ID: 32276276)
1. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
[No Abstract] [Full Text] [Related]
2. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.
Powles T; Stebbing J; Montoto S; Nelson M; Gazzard B; Orkin C; Webb A; Bower M
Blood; 2007 Dec; 110(12):4132-3. PubMed ID: 18024800
[No Abstract] [Full Text] [Related]
5. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
7. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Yarchoan R
Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
[TBL] [Abstract][Full Text] [Related]
8. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.
Aoki Y; Yarchoan R; Wyvill K; Okamoto S; Little RF; Tosato G
Blood; 2001 Apr; 97(7):2173-6. PubMed ID: 11264189
[TBL] [Abstract][Full Text] [Related]
9. HHV8-associated lymphoproliferative disorder in the peripheral blood.
Manogaran C; Kassam S
Blood; 2018 Jun; 131(25):2868. PubMed ID: 29930153
[No Abstract] [Full Text] [Related]
10. [Favorable outcome of Castleman's disease treated with oral valganciclovir].
Valencia ME; Moreno V; Martínez P; Casado I
Med Clin (Barc); 2005 Sep; 125(10):399. PubMed ID: 16185555
[No Abstract] [Full Text] [Related]
11. [Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease].
Mûzes G; Csomor J; Sipos F
Magy Onkol; 2016 Nov; 60(4):328-332. PubMed ID: 27898752
[TBL] [Abstract][Full Text] [Related]
12. How I treat HHV8/KSHV-related diseases in posttransplant patients.
Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment and durable remission of human herpesvirus-8-induced Kaposi sarcoma and multicentric Castleman's disease under valganciclovir in an HIV-negative patient.
Plachouri KM; Oikonomou C; Sarantopoulos A; Koumoundourou D; Georgiou S; Spiliopoulos T
Dermatol Ther; 2020 May; 33(3):e13419. PubMed ID: 32297410
[No Abstract] [Full Text] [Related]
15. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.
Siegel MO; Ghafouri S; Ajmera R; Simon GL
Int J Infect Dis; 2016 Jul; 48():49-51. PubMed ID: 27173076
[TBL] [Abstract][Full Text] [Related]
16. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
Jary A; Leducq V; Palich R; Gothland A; Descamps D; Joly V; Lambert-Niclot S; Amiel C; Canestri A; Mirand A; Gault E; Vabret A; Valantin MA; Katlama C; Calvez V; Dupin N; Spano JP; Marcelin AG
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29643199
[No Abstract] [Full Text] [Related]
18. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
[TBL] [Abstract][Full Text] [Related]
19. New approaches to the treatment of human herpesvirus 8-associated disease.
Casper C
Rev Med Virol; 2008; 18(5):321-9. PubMed ID: 18615774
[TBL] [Abstract][Full Text] [Related]
20. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
